Figure 3

Subgroup analysis of disease-free survival of 351 HCC patients after hepatectomy with different monocyte based on HBV or cirrhosis status. (A) monocyte count could not separate patients with different DFS rates in patients with HBV negative group (P = 0.858). (B) By contrast, monocyte count predicted different DFS rates in patients with HBV positive group (P < 0.001). (C) In addition, DFS was significantly better for the patients with a peripheral blood monocyte count < 545/mm³ than those with monocyte ≥ 545/mm³ in non-cirrhosis group (P = 0.018). (D) DFS was also significantly better for the patients with a peripheral blood monocyte count < 545/mm³ than those with monocyte ≥ 545/mm³ in cirrhosis group (P = 0.002).